SlideShare a Scribd company logo
TOKSIKOLOGI OBATTOKSIKOLOGI OBAT
OBAT YG SERINGOBAT YG SERING
MENYEBABKAN KERACUNANMENYEBABKAN KERACUNAN
 ANTIHISTAMINANTIHISTAMIN
 ANALGETIKAANALGETIKA
 VITAMIN, MINERALVITAMIN, MINERAL
 OBAT FLUOBAT FLU
 HORMONHORMON
 ANTIBIOTIK INTERNALANTIBIOTIK INTERNAL
NONO KRITERIA TOKSIKKRITERIA TOKSIK DOSISDOSIS
11 PRAKTIS NON TOKSIKPRAKTIS NON TOKSIK > 15 G/KG BB> 15 G/KG BB
22 SEDIKIT TOKSIKSEDIKIT TOKSIK 5 – 15 G/KG BB5 – 15 G/KG BB
33 TOKSISITAS SEDANGTOKSISITAS SEDANG 0,5 – 5 G/KG BB0,5 – 5 G/KG BB
44 SANGAT TOKSIKSANGAT TOKSIK 50-500 MG/KG BB50-500 MG/KG BB
55 TOKSIK EKSTREMTOKSIK EKSTREM 5-50 MG/KG BB5-50 MG/KG BB
66 SUPER TOKSIKSUPER TOKSIK < 5 MG/KG BB< 5 MG/KG BB
INDEKS TERAPIINDEKS TERAPI = LD 50 / ED 50= LD 50 / ED 50
MAKINMAKIN BESARBESAR MAKINMAKIN AMANAMAN
URUTAN TOKSISITAS DITINJAU DARIURUTAN TOKSISITAS DITINJAU DARI
RUTE PEMBERIAN:RUTE PEMBERIAN:
IV > INHALASI > IP > SC > IM > INTRAIV > INHALASI > IP > SC > IM > INTRA
DERMAL > ORAL > TOPIKALDERMAL > ORAL > TOPIKAL
EFEKEFEK
TOKSISITASTOKSISITAS
OBATOBAT
EMESISEMESIS SALISILATSALISILAT
KONSTIPASIKONSTIPASI NARKOTIKANARKOTIKA
BRADICARDIBRADICARDI NARKOTIKA, SEDATIVENARKOTIKA, SEDATIVE
TACHICARDITACHICARDI AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN,
SALISILAT, KOKAINSALISILAT, KOKAIN
MULUT KERINGMULUT KERING AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN,
ANTIHISTAMIN,ANTIHISTAMIN,
NARKOTIKNARKOTIK
ATAKSIAATAKSIA BARBITURAT, FENITOIN,BARBITURAT, FENITOIN,
HALUSINOGENHALUSINOGEN
KOMA, DEPRESIKOMA, DEPRESI A.HISTAMIN, A.PSIKOTIKA.HISTAMIN, A.PSIKOTIK
PENANGANAN KERACUNANPENANGANAN KERACUNAN
PENILAIANPENILAIAN
 FUNGSI RESPIRASIFUNGSI RESPIRASI
 FUNGSI KARDIOVASKULARFUNGSI KARDIOVASKULAR
 GEJALA SSPGEJALA SSP
 GEJALA LAINGEJALA LAIN
 PENENTUAN KERACUANANPENENTUAN KERACUANAN
FAKTOR YGFAKTOR YG
MEMPENGARUHIMEMPENGARUHI
TOKSISITASTOKSISITAS
 KOMPOSISIKOMPOSISI
 DOSISDOSIS
 RUTE PEMBERIANRUTE PEMBERIAN
 METABOLISME TOKSIKMETABOLISME TOKSIK
 KONDISI KESEHATANKONDISI KESEHATAN
 USIA KEMATANGANUSIA KEMATANGAN
 KONDISI NUTRISIKONDISI NUTRISI
 GENETIKGENETIK
 KELAMINKELAMIN
 LINGKUNGANLINGKUNGAN
FAKTOR YANG MENENTUKANFAKTOR YANG MENENTUKAN
TOKSISITASTOKSISITAS
LD 50LD 50
EFEK SAMPINGEFEK SAMPING
KECEPATAN TIMBULNYA EFEKKECEPATAN TIMBULNYA EFEK
CARA PENANGANANCARA PENANGANAN
 PENCUCIAN/LAVAGEPENCUCIAN/LAVAGE
 EMESISEMESIS
 ADSORBENTADSORBENT
 KATARTIKKATARTIK
 DEMULSENDEMULSEN
 DEKONTAMINASI TOPIKALDEKONTAMINASI TOPIKAL
 MENINGKATKAN ELIMINASI ZAT TOKSIKMENINGKATKAN ELIMINASI ZAT TOKSIK
 ANTIDOTANTIDOT
PENCUCIANPENCUCIAN
JK RACUN HRS SGR DIKELUATKAN DRJK RACUN HRS SGR DIKELUATKAN DR
LAMBUNGLAMBUNG
INDIKASIINDIKASI
 1010TIDAK SADAR/SETENGAH SADARTIDAK SADAR/SETENGAH SADAR
 REFLEKS MENELAN HILANG:REFLEKS MENELAN HILANG:
S.IPECAC TIDAK BISAS.IPECAC TIDAK BISA
 SANGAT TOKSIK & BANYAKSANGAT TOKSIK & BANYAK
KI :ZAT KOROSIFKI :ZAT KOROSIF
PASIEN KEJANGPASIEN KEJANG
CAIRAN PENCUCIANCAIRAN PENCUCIAN
 NaHCO3NaHCO3
 Larutan Garam CaLarutan Garam Ca
 Larutan As.TanatLarutan As.Tanat
 KMNO4KMNO4
 NaCl FisiologisNaCl Fisiologis
 AirAir
EMESISEMESIS
JK RACUN MASIH DI SAL CERNAJK RACUN MASIH DI SAL CERNA
SIRUP IPECACSIRUP IPECAC
APOMORFINAPOMORFIN
ALTERNATIF LAINALTERNATIF LAIN
LARUTAN SABUNLARUTAN SABUN
RANGSANGAN MEKANIKRANGSANGAN MEKANIK
KI:KI: OBAT KONVULSANOBAT KONVULSAN
TDK SADAR/REFLEKS MENELAN –TDK SADAR/REFLEKS MENELAN –
PENYAKIT CARDIOVASKULARPENYAKIT CARDIOVASKULAR
EMPISEMAEMPISEMA
ADSORBENADSORBEN
JK RACUN DPT DIABS D/ ABSORBENJK RACUN DPT DIABS D/ ABSORBEN
 KARBON AKTIFKARBON AKTIF
 KAOLINKAOLIN
 PEKTINPEKTIN
 ATALPUGITATALPUGIT
 KOLESTIRAMINKOLESTIRAMIN
ABSORBSI < :TOLBUTAMID, ZAT TDKABSORBSI < :TOLBUTAMID, ZAT TDK
LRT AIRLRT AIR
KATARTIK
JK DIDUGA ZAT TOKSIK SDH MSK USUS
 MgSO4
 Mg SITRAT
 Na SULFAT
 Na FOSFAT
 SORBITOL
 Sbg pencahar
DEMULSEN
• ES KRIM
• SUSU
• PUTIH TELUR
 Lapisi muk zat
racun yg korosif
DEKONTAMINASI
TOPIKAL
• AIR
• SABUN
 u/ zat iritan
PENINGKATAN ELIMINASIPENINGKATAN ELIMINASI
 DIURETIK KUATDIURETIK KUAT
 Yg dpt dikeluarkan diuretik kuatYg dpt dikeluarkan diuretik kuat
amfetamin,penicillin,salisilat,sulfonamidaamfetamin,penicillin,salisilat,sulfonamida
KI : ACETAMINOPHEN,FENOTIAZINKI : ACETAMINOPHEN,FENOTIAZIN
A.DEPRESSAN TRISIKLIK,barbiturat krjA.DEPRESSAN TRISIKLIK,barbiturat krj
pendekpendek
**DIALISISDIALISIS
*PENGASAMAN/PEMBASAAN URIN*PENGASAMAN/PEMBASAAN URIN
ANTIDOTANTIDOT
 KIMIAKIMIA
 RESEPTORRESEPTOR
 DISPOSIONALDISPOSIONAL
 FUNGSIONAL/FISIOLOGISFUNGSIONAL/FISIOLOGIS
 ANTIDOTANTIDOT
ATROPIN----------------ATROPIN----------------
DIAZEPAM--------------DIAZEPAM--------------
DEKTROSE-------------DEKTROSE-------------
ADRENALIN------------ADRENALIN------------
DOPAMIN---------------DOPAMIN---------------
NALOKSON-------------NALOKSON-------------
NITROPRUSID---------NITROPRUSID---------
--
PROTAMIN SULFAT--PROTAMIN SULFAT--
VIT K-----------------VIT K-----------------
ASETILASETIL
SISTEIN-----SISTEIN-----
 RACUN/GEJALARACUN/GEJALA
KOLINESTERASE INHKOLINESTERASE INH
STIMULAN SSPSTIMULAN SSP
HIPOGLIKEMIKHIPOGLIKEMIK
ANAPHYLAKSIISANAPHYLAKSIIS
HIPOTENSIHIPOTENSI
OPIOIDOPIOID
HIPERTENSIHIPERTENSI
HEPARINHEPARIN
ANTIKOAGULANORALANTIKOAGULANORAL
ACHETAMINOPHENACHETAMINOPHEN
KERACUNAN ACETAMINOPHEN
 MK: METABOLIT REAKTIF IK SEL
NECROSIS
HB MET HB(TDK IK O2)
O2
PAR
HB
(ENZ MET HB REDUKTASE)
KOFAKTOR : GLUTATION
• AnjAnj  nekrosis hepatiknekrosis hepatik
• KucKuc Met HemoglobinemiaMet Hemoglobinemia
DOSIS TOKSIKDOSIS TOKSIK
ANJ : 150 MG/KGANJ : 150 MG/KG
KUC : 50 MG/KGKUC : 50 MG/KG
(DOSIS AN: 80 MG(DOSIS AN: 80 MG
REG: 325-500MG)REG: 325-500MG)
GEJALAGEJALA
► ANJ: - DEPRESIANJ: - DEPRESI
- MUNTAH- MUNTAH
- SKT ABD- SKT ABD
- URIN,SERUM: GELAP- URIN,SERUM: GELAP
- MATI ( 2-5 HR)- MATI ( 2-5 HR)
► KUCKUC
- ANOREKSI,SALIVASI,VOMIT- ANOREKSI,SALIVASI,VOMIT
- DEPRESI- DEPRESI
- METHBNEMIA, HEMOGLOBINURIA- METHBNEMIA, HEMOGLOBINURIA
- MEMBRAN CYANOTIK- MEMBRAN CYANOTIK
- URIN, DARAH GELAP- URIN, DARAH GELAP
- WAJAH EDEMA- WAJAH EDEMA
- MATI 18-36 J- MATI 18-36 J
 PROGNOSIS: JELEKPROGNOSIS: JELEK
 TREATMENTTREATMENT
- <4J: EMESIS, GASTRIC LAVAGE,- <4J: EMESIS, GASTRIC LAVAGE,
ACTIVATED CHARCOALACTIVATED CHARCOAL
KUC: YOHIMBINKUC: YOHIMBIN
ANJ: APOMORPHINANJ: APOMORPHIN
-GROUP SULFHYDRYL:N--GROUP SULFHYDRYL:N-
ACETILCYSTEINE 140 MG/KGACETILCYSTEINE 140 MG/KG
- VIT C- VIT C
- SUPPORTIVE THERAPY- SUPPORTIVE THERAPY
-INFUSE : DECTROSE 2,5%-INFUSE : DECTROSE 2,5%
-OXYGEN:-OXYGEN:
-TRANSFUSI DRH-TRANSFUSI DRH
ASPIRIN TOXICOSISASPIRIN TOXICOSIS
 KUC > SERING DRPD ANJKUC > SERING DRPD ANJ
C/ KUC:DEF/AKTC/ KUC:DEF/AKT GLUCORONYLGLUCORONYL
TRANSFERASETRANSFERASE <<
(GT : DETOX & EKS ASPIRIN)(GT : DETOX & EKS ASPIRIN)
EFEK TOKSIK:EFEK TOKSIK:
- TEKAN SUTUL- TEKAN SUTUL
- HAMB AGREGASI TROMBOSIT- HAMB AGREGASI TROMBOSIT
- METABOLIC ACIDOSIS- METABOLIC ACIDOSIS
- RENAL DISEASE- RENAL DISEASE
- GASTRIC ULCERASI- GASTRIC ULCERASI
DOSIS TOXIC:DOSIS TOXIC:
- ANJ : 30 MG /KG/HR- ANJ : 30 MG /KG/HR
- KUC : 25 MG/KG/HR- KUC : 25 MG/KG/HR
(ANAK : 81 MG(ANAK : 81 MG
REG : 325- 500 MG)REG : 325- 500 MG)
GJL:-AKUT:GJL:-AKUT:
DEPRESI, ANOREKSI,DEPRESI, ANOREKSI,
HIPERPIREXIA, VOMIT,HIPERPIREXIA, VOMIT,
ATAKSIA,ATAKSIA,
COMA, MATICOMA, MATI
 KRONIK:KRONIK:
GASTRIK ULCER, PERFORASI,GASTRIK ULCER, PERFORASI,
HEPATOTIKSIK, SUPRESI SUTULHEPATOTIKSIK, SUPRESI SUTUL
TREATMENTTREATMENT
1. 6-12 J : EMETIK,GASTREK1. 6-12 J : EMETIK,GASTREK
LAVAGE,LAVAGE,
ACT CHARCOAL, SALINEACT CHARCOAL, SALINE
CATARTIKCATARTIK
2. DIURESIS : DIURETIK KUAT2. DIURESIS : DIURETIK KUAT
IBUPROFENIBUPROFEN
 NSAID YG TDK DIREKOMENDASI UTKNSAID YG TDK DIREKOMENDASI UTK
PETSPETS  IT SEMPITIT SEMPIT
 TOKSISITAS:TOKSISITAS:
- 150 mg/kg- 150 mg/kg vomit, gastric ulcervomit, gastric ulcer
- 300 mg/kg- 300 mg/kg  ggl ginjalggl ginjal
 PROG : JLKPROG : JLK
 TREAT: 1. EMETIK, GASTRIK L, ATREAT: 1. EMETIK, GASTRIK L, A
CHARCOALCHARCOAL
2. support: infus, diuresis2. support: infus, diuresis
3. simpt: sucralfat, ranitidin,3. simpt: sucralfat, ranitidin,
misotrostolmisotrostol g.ulcerg.ulcer
ANTICOAGULANT
 MK : -INH ENZ PD SINTESIS VIT K
- INH FACT COAG PROD VIT K
 TOXIC DOSE
* ANJ : 5-300 MG/KG
(1-5 MG/KG/HR 5-15 HR)
* KUC: 5-30 MG/KG
(1 MG/KG/HR 5 HR)
 GJL:- DEPRESI,LEMAH
- HEMATEMESIS,HEMATURIA,HEMORRHAGE
- MATI HEMORRHAGE D/PLEURAL CAVITY
 DX:-HISTORY
- SCREENING KOAG: BLEEDING TIME, COAG TIME
- ANALISIS A.COAG KIMIA
• TREATMENT
1. INDUKSI EMESIS, GASTRIC LAVAGE, ACTIVED
CHATCOAL, CATHARTIC
2. ANTIDOTE: VIT K
3. TREAT CLINICAL SIGN
- INTRAPULMONARY HEMORRHAGE:
TRANSFUSI PLASMA, O2, TDK BOLEH
DIBERI FUROSEMIDE INH FS PLATELET
- HIPOVOLEMIC SHOCK: INFUSE,TRANSF
DRH, KORTICOSTEROID,
A.HISTAMIN&DECONGESTAN
 DX: SEJARAH PSEUDOEPHEDRIN,
(PHENYLPROPANOLAMINE)/PPA,DIPHENH
YDRAMINE, CHLORPHENIRAMINE
 GJL:- DEPRESI, GG RESP,
- HIPEREXCITABILITY
- TREMOR, SEIZURES, HIPERACTIVITY
- VOMIT, MIDRIASIS, HIPERTERMIA
- DISORIENTASI
- BRADICARD/TACHICARD
 PROG: BAIK
 TREAT:
1. < 1 J INTAKEEMESIS
2. ACTIVATED CHARCOAL
3. SUPPORTIVE: INFUSE, O2
4. OBAT SEDATIVE HIPERACVTIVE
(DIAZEPAM,PHENOBARBITAL)
5. PROPANOLOLTACHYCARDI
6. ATROPINE BRADYCARD

More Related Content

What's hot

EKSPEKTORAN & MUKOLITIK
EKSPEKTORAN & MUKOLITIKEKSPEKTORAN & MUKOLITIK
EKSPEKTORAN & MUKOLITIK
Sapan Nada
 
Patofisiologi hipertensi
Patofisiologi hipertensiPatofisiologi hipertensi
Patofisiologi hipertensi
SofiaNofianti
 
Obat sistem endokrin
Obat sistem endokrin Obat sistem endokrin
Obat sistem endokrin
Dedi Kun
 
PENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKPENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIK
Surya Amal
 
Obat saluran pernafasan
Obat saluran pernafasan Obat saluran pernafasan
Obat saluran pernafasan Dedi Kun
 
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
Bagus Utomo
 
Perhitungan Obat pada Anak
Perhitungan Obat pada Anak Perhitungan Obat pada Anak
Perhitungan Obat pada Anak
Amalia Senja
 
penggolongan obat menurut pemerintah
 penggolongan obat menurut pemerintah penggolongan obat menurut pemerintah
penggolongan obat menurut pemerintahGdiss Yogaswara
 
Pengenalan resep
Pengenalan resepPengenalan resep
Pengenalan resep
Tazkiyatan Isria
 
PENGGOLONGAN DAN BENTUK SEDIAAN OBAT
PENGGOLONGAN DAN BENTUK SEDIAAN OBATPENGGOLONGAN DAN BENTUK SEDIAAN OBAT
PENGGOLONGAN DAN BENTUK SEDIAAN OBAT
Surya Amal
 
Toksikokinetik,slideshare
Toksikokinetik,slideshareToksikokinetik,slideshare
Toksikokinetik,slideshareInoy Trisnaini
 
Obat saluran pencernaan
Obat saluran pencernaanObat saluran pencernaan
Obat saluran pencernaan
Rizkythia_Andhara
 
Interaksi obat
Interaksi obatInteraksi obat
Interaksi obat
Yuyun Yagami
 
Farmakoterapi pendahuluan
Farmakoterapi pendahuluanFarmakoterapi pendahuluan
Farmakoterapi pendahuluan
Dnr Creatives
 
Farmakologi (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
Farmakologi  (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)Farmakologi  (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
Farmakologi (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
Surya Amal
 
Toksikologi 2017
Toksikologi 2017Toksikologi 2017
Toksikologi 2017
Fadhol Romdhoni
 

What's hot (20)

EKSPEKTORAN & MUKOLITIK
EKSPEKTORAN & MUKOLITIKEKSPEKTORAN & MUKOLITIK
EKSPEKTORAN & MUKOLITIK
 
Patofisiologi hipertensi
Patofisiologi hipertensiPatofisiologi hipertensi
Patofisiologi hipertensi
 
Obat sistem endokrin
Obat sistem endokrin Obat sistem endokrin
Obat sistem endokrin
 
PENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKPENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIK
 
TOKSIKOLOGI
TOKSIKOLOGITOKSIKOLOGI
TOKSIKOLOGI
 
Obat saluran pernafasan
Obat saluran pernafasan Obat saluran pernafasan
Obat saluran pernafasan
 
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
Obat-obatan Antipsikotik (terjemahan bahasa indonesia, 2.0)
 
Perhitungan Obat pada Anak
Perhitungan Obat pada Anak Perhitungan Obat pada Anak
Perhitungan Obat pada Anak
 
penggolongan obat menurut pemerintah
 penggolongan obat menurut pemerintah penggolongan obat menurut pemerintah
penggolongan obat menurut pemerintah
 
Laporan kasus gastritis
Laporan kasus gastritisLaporan kasus gastritis
Laporan kasus gastritis
 
Pengenalan resep
Pengenalan resepPengenalan resep
Pengenalan resep
 
Diare
DiareDiare
Diare
 
PENGGOLONGAN DAN BENTUK SEDIAAN OBAT
PENGGOLONGAN DAN BENTUK SEDIAAN OBATPENGGOLONGAN DAN BENTUK SEDIAAN OBAT
PENGGOLONGAN DAN BENTUK SEDIAAN OBAT
 
Toksikokinetik,slideshare
Toksikokinetik,slideshareToksikokinetik,slideshare
Toksikokinetik,slideshare
 
Obat saluran pencernaan
Obat saluran pencernaanObat saluran pencernaan
Obat saluran pencernaan
 
Interaksi obat
Interaksi obatInteraksi obat
Interaksi obat
 
Farmakoterapi pendahuluan
Farmakoterapi pendahuluanFarmakoterapi pendahuluan
Farmakoterapi pendahuluan
 
Pedoman farmakoekonomi
Pedoman farmakoekonomiPedoman farmakoekonomi
Pedoman farmakoekonomi
 
Farmakologi (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
Farmakologi  (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)Farmakologi  (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
Farmakologi (Prinsip-Prinsip Terapeutika, Keamanan, dan Efikasi Pengobatan)
 
Toksikologi 2017
Toksikologi 2017Toksikologi 2017
Toksikologi 2017
 

Similar to TOKSIKOLOGI OBAT

Pituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic managementPituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic management
Unnikrishnan Prathapadas
 
5. pharma musculoskeletal system
5. pharma musculoskeletal system5. pharma musculoskeletal system
5. pharma musculoskeletal system
jhonee balmeo
 
Newer drugs in management of glaucoma
Newer drugs in management of glaucomaNewer drugs in management of glaucoma
Newer drugs in management of glaucoma
DrArvindMorya
 
COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....
V467
 
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritisDisease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
BipulBorthakur
 
CASE STUDY GERD
CASE STUDY GERDCASE STUDY GERD
CASE STUDY GERD
AnilDhakal14
 
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda JainOBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
Lifecare Centre
 
Osteoporosis treatment & surgical significance
Osteoporosis  treatment & surgical significanceOsteoporosis  treatment & surgical significance
Osteoporosis treatment & surgical significance
Vinoth Kumar
 
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptxDIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
subhayan999
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
najmishafiz
 
Respiratory illness treatment
Respiratory illness treatmentRespiratory illness treatment
Respiratory illness treatment
Kamal Sharma
 
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttxHYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
titi224002
 
1362566341 surgical treatment of diabetic foot
1362566341 surgical treatment of diabetic foot1362566341 surgical treatment of diabetic foot
1362566341 surgical treatment of diabetic foot
dfsimedia
 
Corticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptxCorticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptx
SiddharthSingh639
 
Factors affecting drug action pdf
Factors affecting drug action pdfFactors affecting drug action pdf
Factors affecting drug action pdf
AarushiSharma54
 
Drugs for neutropenia
Drugs for neutropeniaDrugs for neutropenia
Drugs for neutropeniaDeepak Anand
 
penyakit infeksi pada anak
penyakit infeksi pada anakpenyakit infeksi pada anak
penyakit infeksi pada anakKindal
 
Dr tarek NSAIDs
Dr tarek NSAIDsDr tarek NSAIDs
Dr tarek NSAIDs
al azhar universty
 

Similar to TOKSIKOLOGI OBAT (20)

Pituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic managementPituitary gland disorders and anesthetic management
Pituitary gland disorders and anesthetic management
 
5. pharma musculoskeletal system
5. pharma musculoskeletal system5. pharma musculoskeletal system
5. pharma musculoskeletal system
 
Steroids ppt
Steroids pptSteroids ppt
Steroids ppt
 
Newer drugs in management of glaucoma
Newer drugs in management of glaucomaNewer drugs in management of glaucoma
Newer drugs in management of glaucoma
 
COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....COPD COMPLETE POWER POINT AS PER GOLD....
COPD COMPLETE POWER POINT AS PER GOLD....
 
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritisDisease modifying anti rheumatoid drugs in rheumatoid arhtritis
Disease modifying anti rheumatoid drugs in rheumatoid arhtritis
 
CASE STUDY GERD
CASE STUDY GERDCASE STUDY GERD
CASE STUDY GERD
 
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda JainOBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
OBESITY,NUTRITION, METABOLIC SYNDROME update Dr Rahul Jain & Dr Sharda Jain
 
Osteoporosis treatment & surgical significance
Osteoporosis  treatment & surgical significanceOsteoporosis  treatment & surgical significance
Osteoporosis treatment & surgical significance
 
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptxDIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
DIAGNOSTIC APPROACH AND MANAGEMENT OF ACUTE KIDNEY INJURY - Copy.pptx
 
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdfBASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
BASIC ICU & OT NOTES 2021 (VERSION 3) FINAL.pdf
 
Respiratory illness treatment
Respiratory illness treatmentRespiratory illness treatment
Respiratory illness treatment
 
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttxHYPERGLYCEMIA ppt puskesmas anamnesis ttx
HYPERGLYCEMIA ppt puskesmas anamnesis ttx
 
1362566341 surgical treatment of diabetic foot
1362566341 surgical treatment of diabetic foot1362566341 surgical treatment of diabetic foot
1362566341 surgical treatment of diabetic foot
 
Corticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptxCorticosteroids in dentistry - DIVYA SINGH.pptx
Corticosteroids in dentistry - DIVYA SINGH.pptx
 
Hemostatika
HemostatikaHemostatika
Hemostatika
 
Factors affecting drug action pdf
Factors affecting drug action pdfFactors affecting drug action pdf
Factors affecting drug action pdf
 
Drugs for neutropenia
Drugs for neutropeniaDrugs for neutropenia
Drugs for neutropenia
 
penyakit infeksi pada anak
penyakit infeksi pada anakpenyakit infeksi pada anak
penyakit infeksi pada anak
 
Dr tarek NSAIDs
Dr tarek NSAIDsDr tarek NSAIDs
Dr tarek NSAIDs
 

Recently uploaded

Acorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutesAcorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutes
IP ServerOne
 
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXOBitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Matjaž Lipuš
 
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdfBonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
khadija278284
 
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Sebastiano Panichella
 
Getting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control TowerGetting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control Tower
Vladimir Samoylov
 
International Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software TestingInternational Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software Testing
Sebastiano Panichella
 
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
OECD Directorate for Financial and Enterprise Affairs
 
Eureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 PresentationEureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 Presentation
Access Innovations, Inc.
 
María Carolina Martínez - eCommerce Day Colombia 2024
María Carolina Martínez - eCommerce Day Colombia 2024María Carolina Martínez - eCommerce Day Colombia 2024
María Carolina Martínez - eCommerce Day Colombia 2024
eCommerce Institute
 
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdfSupercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
Access Innovations, Inc.
 
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptxsomanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
Howard Spence
 
Media as a Mind Controlling Strategy In Old and Modern Era
Media as a Mind Controlling Strategy In Old and Modern EraMedia as a Mind Controlling Strategy In Old and Modern Era
Media as a Mind Controlling Strategy In Old and Modern Era
faizulhassanfaiz1670
 
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
0x01 - Newton's Third Law:  Static vs. Dynamic Abusers0x01 - Newton's Third Law:  Static vs. Dynamic Abusers
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
OWASP Beja
 
Obesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditionsObesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditions
Faculty of Medicine And Health Sciences
 
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Sebastiano Panichella
 
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Orkestra
 

Recently uploaded (16)

Acorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutesAcorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutes
 
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXOBitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXO
 
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdfBonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
 
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
 
Getting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control TowerGetting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control Tower
 
International Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software TestingInternational Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software Testing
 
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
 
Eureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 PresentationEureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 Presentation
 
María Carolina Martínez - eCommerce Day Colombia 2024
María Carolina Martínez - eCommerce Day Colombia 2024María Carolina Martínez - eCommerce Day Colombia 2024
María Carolina Martínez - eCommerce Day Colombia 2024
 
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdfSupercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
Supercharge your AI - SSP Industry Breakout Session 2024-v2_1.pdf
 
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptxsomanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
 
Media as a Mind Controlling Strategy In Old and Modern Era
Media as a Mind Controlling Strategy In Old and Modern EraMedia as a Mind Controlling Strategy In Old and Modern Era
Media as a Mind Controlling Strategy In Old and Modern Era
 
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
0x01 - Newton's Third Law:  Static vs. Dynamic Abusers0x01 - Newton's Third Law:  Static vs. Dynamic Abusers
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
 
Obesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditionsObesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditions
 
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...
 
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
 

TOKSIKOLOGI OBAT

  • 2. OBAT YG SERINGOBAT YG SERING MENYEBABKAN KERACUNANMENYEBABKAN KERACUNAN  ANTIHISTAMINANTIHISTAMIN  ANALGETIKAANALGETIKA  VITAMIN, MINERALVITAMIN, MINERAL  OBAT FLUOBAT FLU  HORMONHORMON  ANTIBIOTIK INTERNALANTIBIOTIK INTERNAL
  • 3. NONO KRITERIA TOKSIKKRITERIA TOKSIK DOSISDOSIS 11 PRAKTIS NON TOKSIKPRAKTIS NON TOKSIK > 15 G/KG BB> 15 G/KG BB 22 SEDIKIT TOKSIKSEDIKIT TOKSIK 5 – 15 G/KG BB5 – 15 G/KG BB 33 TOKSISITAS SEDANGTOKSISITAS SEDANG 0,5 – 5 G/KG BB0,5 – 5 G/KG BB 44 SANGAT TOKSIKSANGAT TOKSIK 50-500 MG/KG BB50-500 MG/KG BB 55 TOKSIK EKSTREMTOKSIK EKSTREM 5-50 MG/KG BB5-50 MG/KG BB 66 SUPER TOKSIKSUPER TOKSIK < 5 MG/KG BB< 5 MG/KG BB
  • 4. INDEKS TERAPIINDEKS TERAPI = LD 50 / ED 50= LD 50 / ED 50 MAKINMAKIN BESARBESAR MAKINMAKIN AMANAMAN URUTAN TOKSISITAS DITINJAU DARIURUTAN TOKSISITAS DITINJAU DARI RUTE PEMBERIAN:RUTE PEMBERIAN: IV > INHALASI > IP > SC > IM > INTRAIV > INHALASI > IP > SC > IM > INTRA DERMAL > ORAL > TOPIKALDERMAL > ORAL > TOPIKAL
  • 5. EFEKEFEK TOKSISITASTOKSISITAS OBATOBAT EMESISEMESIS SALISILATSALISILAT KONSTIPASIKONSTIPASI NARKOTIKANARKOTIKA BRADICARDIBRADICARDI NARKOTIKA, SEDATIVENARKOTIKA, SEDATIVE TACHICARDITACHICARDI AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN, SALISILAT, KOKAINSALISILAT, KOKAIN MULUT KERINGMULUT KERING AMFETAMIN, ATROPIN,AMFETAMIN, ATROPIN, ANTIHISTAMIN,ANTIHISTAMIN, NARKOTIKNARKOTIK ATAKSIAATAKSIA BARBITURAT, FENITOIN,BARBITURAT, FENITOIN, HALUSINOGENHALUSINOGEN KOMA, DEPRESIKOMA, DEPRESI A.HISTAMIN, A.PSIKOTIKA.HISTAMIN, A.PSIKOTIK
  • 6. PENANGANAN KERACUNANPENANGANAN KERACUNAN PENILAIANPENILAIAN  FUNGSI RESPIRASIFUNGSI RESPIRASI  FUNGSI KARDIOVASKULARFUNGSI KARDIOVASKULAR  GEJALA SSPGEJALA SSP  GEJALA LAINGEJALA LAIN  PENENTUAN KERACUANANPENENTUAN KERACUANAN
  • 7. FAKTOR YGFAKTOR YG MEMPENGARUHIMEMPENGARUHI TOKSISITASTOKSISITAS  KOMPOSISIKOMPOSISI  DOSISDOSIS  RUTE PEMBERIANRUTE PEMBERIAN  METABOLISME TOKSIKMETABOLISME TOKSIK  KONDISI KESEHATANKONDISI KESEHATAN  USIA KEMATANGANUSIA KEMATANGAN  KONDISI NUTRISIKONDISI NUTRISI  GENETIKGENETIK  KELAMINKELAMIN  LINGKUNGANLINGKUNGAN
  • 8. FAKTOR YANG MENENTUKANFAKTOR YANG MENENTUKAN TOKSISITASTOKSISITAS LD 50LD 50 EFEK SAMPINGEFEK SAMPING KECEPATAN TIMBULNYA EFEKKECEPATAN TIMBULNYA EFEK
  • 9. CARA PENANGANANCARA PENANGANAN  PENCUCIAN/LAVAGEPENCUCIAN/LAVAGE  EMESISEMESIS  ADSORBENTADSORBENT  KATARTIKKATARTIK  DEMULSENDEMULSEN  DEKONTAMINASI TOPIKALDEKONTAMINASI TOPIKAL  MENINGKATKAN ELIMINASI ZAT TOKSIKMENINGKATKAN ELIMINASI ZAT TOKSIK  ANTIDOTANTIDOT
  • 10. PENCUCIANPENCUCIAN JK RACUN HRS SGR DIKELUATKAN DRJK RACUN HRS SGR DIKELUATKAN DR LAMBUNGLAMBUNG INDIKASIINDIKASI  1010TIDAK SADAR/SETENGAH SADARTIDAK SADAR/SETENGAH SADAR  REFLEKS MENELAN HILANG:REFLEKS MENELAN HILANG: S.IPECAC TIDAK BISAS.IPECAC TIDAK BISA  SANGAT TOKSIK & BANYAKSANGAT TOKSIK & BANYAK
  • 11. KI :ZAT KOROSIFKI :ZAT KOROSIF PASIEN KEJANGPASIEN KEJANG CAIRAN PENCUCIANCAIRAN PENCUCIAN  NaHCO3NaHCO3  Larutan Garam CaLarutan Garam Ca  Larutan As.TanatLarutan As.Tanat  KMNO4KMNO4  NaCl FisiologisNaCl Fisiologis  AirAir
  • 12. EMESISEMESIS JK RACUN MASIH DI SAL CERNAJK RACUN MASIH DI SAL CERNA SIRUP IPECACSIRUP IPECAC APOMORFINAPOMORFIN ALTERNATIF LAINALTERNATIF LAIN LARUTAN SABUNLARUTAN SABUN RANGSANGAN MEKANIKRANGSANGAN MEKANIK KI:KI: OBAT KONVULSANOBAT KONVULSAN TDK SADAR/REFLEKS MENELAN –TDK SADAR/REFLEKS MENELAN – PENYAKIT CARDIOVASKULARPENYAKIT CARDIOVASKULAR EMPISEMAEMPISEMA
  • 13. ADSORBENADSORBEN JK RACUN DPT DIABS D/ ABSORBENJK RACUN DPT DIABS D/ ABSORBEN  KARBON AKTIFKARBON AKTIF  KAOLINKAOLIN  PEKTINPEKTIN  ATALPUGITATALPUGIT  KOLESTIRAMINKOLESTIRAMIN ABSORBSI < :TOLBUTAMID, ZAT TDKABSORBSI < :TOLBUTAMID, ZAT TDK LRT AIRLRT AIR
  • 14. KATARTIK JK DIDUGA ZAT TOKSIK SDH MSK USUS  MgSO4  Mg SITRAT  Na SULFAT  Na FOSFAT  SORBITOL  Sbg pencahar
  • 15. DEMULSEN • ES KRIM • SUSU • PUTIH TELUR  Lapisi muk zat racun yg korosif DEKONTAMINASI TOPIKAL • AIR • SABUN  u/ zat iritan
  • 16. PENINGKATAN ELIMINASIPENINGKATAN ELIMINASI  DIURETIK KUATDIURETIK KUAT  Yg dpt dikeluarkan diuretik kuatYg dpt dikeluarkan diuretik kuat amfetamin,penicillin,salisilat,sulfonamidaamfetamin,penicillin,salisilat,sulfonamida KI : ACETAMINOPHEN,FENOTIAZINKI : ACETAMINOPHEN,FENOTIAZIN A.DEPRESSAN TRISIKLIK,barbiturat krjA.DEPRESSAN TRISIKLIK,barbiturat krj pendekpendek **DIALISISDIALISIS *PENGASAMAN/PEMBASAAN URIN*PENGASAMAN/PEMBASAAN URIN
  • 17. ANTIDOTANTIDOT  KIMIAKIMIA  RESEPTORRESEPTOR  DISPOSIONALDISPOSIONAL  FUNGSIONAL/FISIOLOGISFUNGSIONAL/FISIOLOGIS
  • 18.  ANTIDOTANTIDOT ATROPIN----------------ATROPIN---------------- DIAZEPAM--------------DIAZEPAM-------------- DEKTROSE-------------DEKTROSE------------- ADRENALIN------------ADRENALIN------------ DOPAMIN---------------DOPAMIN--------------- NALOKSON-------------NALOKSON------------- NITROPRUSID---------NITROPRUSID--------- -- PROTAMIN SULFAT--PROTAMIN SULFAT-- VIT K-----------------VIT K----------------- ASETILASETIL SISTEIN-----SISTEIN-----  RACUN/GEJALARACUN/GEJALA KOLINESTERASE INHKOLINESTERASE INH STIMULAN SSPSTIMULAN SSP HIPOGLIKEMIKHIPOGLIKEMIK ANAPHYLAKSIISANAPHYLAKSIIS HIPOTENSIHIPOTENSI OPIOIDOPIOID HIPERTENSIHIPERTENSI HEPARINHEPARIN ANTIKOAGULANORALANTIKOAGULANORAL ACHETAMINOPHENACHETAMINOPHEN
  • 19. KERACUNAN ACETAMINOPHEN  MK: METABOLIT REAKTIF IK SEL NECROSIS HB MET HB(TDK IK O2) O2 PAR HB (ENZ MET HB REDUKTASE) KOFAKTOR : GLUTATION
  • 20.
  • 21. • AnjAnj  nekrosis hepatiknekrosis hepatik • KucKuc Met HemoglobinemiaMet Hemoglobinemia DOSIS TOKSIKDOSIS TOKSIK ANJ : 150 MG/KGANJ : 150 MG/KG KUC : 50 MG/KGKUC : 50 MG/KG (DOSIS AN: 80 MG(DOSIS AN: 80 MG REG: 325-500MG)REG: 325-500MG)
  • 22. GEJALAGEJALA ► ANJ: - DEPRESIANJ: - DEPRESI - MUNTAH- MUNTAH - SKT ABD- SKT ABD - URIN,SERUM: GELAP- URIN,SERUM: GELAP - MATI ( 2-5 HR)- MATI ( 2-5 HR) ► KUCKUC - ANOREKSI,SALIVASI,VOMIT- ANOREKSI,SALIVASI,VOMIT - DEPRESI- DEPRESI - METHBNEMIA, HEMOGLOBINURIA- METHBNEMIA, HEMOGLOBINURIA - MEMBRAN CYANOTIK- MEMBRAN CYANOTIK - URIN, DARAH GELAP- URIN, DARAH GELAP - WAJAH EDEMA- WAJAH EDEMA - MATI 18-36 J- MATI 18-36 J
  • 23.  PROGNOSIS: JELEKPROGNOSIS: JELEK  TREATMENTTREATMENT - <4J: EMESIS, GASTRIC LAVAGE,- <4J: EMESIS, GASTRIC LAVAGE, ACTIVATED CHARCOALACTIVATED CHARCOAL KUC: YOHIMBINKUC: YOHIMBIN ANJ: APOMORPHINANJ: APOMORPHIN -GROUP SULFHYDRYL:N--GROUP SULFHYDRYL:N- ACETILCYSTEINE 140 MG/KGACETILCYSTEINE 140 MG/KG - VIT C- VIT C - SUPPORTIVE THERAPY- SUPPORTIVE THERAPY -INFUSE : DECTROSE 2,5%-INFUSE : DECTROSE 2,5% -OXYGEN:-OXYGEN: -TRANSFUSI DRH-TRANSFUSI DRH
  • 24. ASPIRIN TOXICOSISASPIRIN TOXICOSIS  KUC > SERING DRPD ANJKUC > SERING DRPD ANJ C/ KUC:DEF/AKTC/ KUC:DEF/AKT GLUCORONYLGLUCORONYL TRANSFERASETRANSFERASE << (GT : DETOX & EKS ASPIRIN)(GT : DETOX & EKS ASPIRIN) EFEK TOKSIK:EFEK TOKSIK: - TEKAN SUTUL- TEKAN SUTUL - HAMB AGREGASI TROMBOSIT- HAMB AGREGASI TROMBOSIT - METABOLIC ACIDOSIS- METABOLIC ACIDOSIS - RENAL DISEASE- RENAL DISEASE - GASTRIC ULCERASI- GASTRIC ULCERASI
  • 25. DOSIS TOXIC:DOSIS TOXIC: - ANJ : 30 MG /KG/HR- ANJ : 30 MG /KG/HR - KUC : 25 MG/KG/HR- KUC : 25 MG/KG/HR (ANAK : 81 MG(ANAK : 81 MG REG : 325- 500 MG)REG : 325- 500 MG) GJL:-AKUT:GJL:-AKUT: DEPRESI, ANOREKSI,DEPRESI, ANOREKSI, HIPERPIREXIA, VOMIT,HIPERPIREXIA, VOMIT, ATAKSIA,ATAKSIA, COMA, MATICOMA, MATI
  • 26.  KRONIK:KRONIK: GASTRIK ULCER, PERFORASI,GASTRIK ULCER, PERFORASI, HEPATOTIKSIK, SUPRESI SUTULHEPATOTIKSIK, SUPRESI SUTUL TREATMENTTREATMENT 1. 6-12 J : EMETIK,GASTREK1. 6-12 J : EMETIK,GASTREK LAVAGE,LAVAGE, ACT CHARCOAL, SALINEACT CHARCOAL, SALINE CATARTIKCATARTIK 2. DIURESIS : DIURETIK KUAT2. DIURESIS : DIURETIK KUAT
  • 27. IBUPROFENIBUPROFEN  NSAID YG TDK DIREKOMENDASI UTKNSAID YG TDK DIREKOMENDASI UTK PETSPETS  IT SEMPITIT SEMPIT  TOKSISITAS:TOKSISITAS: - 150 mg/kg- 150 mg/kg vomit, gastric ulcervomit, gastric ulcer - 300 mg/kg- 300 mg/kg  ggl ginjalggl ginjal  PROG : JLKPROG : JLK  TREAT: 1. EMETIK, GASTRIK L, ATREAT: 1. EMETIK, GASTRIK L, A CHARCOALCHARCOAL 2. support: infus, diuresis2. support: infus, diuresis 3. simpt: sucralfat, ranitidin,3. simpt: sucralfat, ranitidin, misotrostolmisotrostol g.ulcerg.ulcer
  • 28. ANTICOAGULANT  MK : -INH ENZ PD SINTESIS VIT K - INH FACT COAG PROD VIT K  TOXIC DOSE * ANJ : 5-300 MG/KG (1-5 MG/KG/HR 5-15 HR) * KUC: 5-30 MG/KG (1 MG/KG/HR 5 HR)  GJL:- DEPRESI,LEMAH - HEMATEMESIS,HEMATURIA,HEMORRHAGE - MATI HEMORRHAGE D/PLEURAL CAVITY  DX:-HISTORY - SCREENING KOAG: BLEEDING TIME, COAG TIME - ANALISIS A.COAG KIMIA
  • 29. • TREATMENT 1. INDUKSI EMESIS, GASTRIC LAVAGE, ACTIVED CHATCOAL, CATHARTIC 2. ANTIDOTE: VIT K 3. TREAT CLINICAL SIGN - INTRAPULMONARY HEMORRHAGE: TRANSFUSI PLASMA, O2, TDK BOLEH DIBERI FUROSEMIDE INH FS PLATELET - HIPOVOLEMIC SHOCK: INFUSE,TRANSF DRH, KORTICOSTEROID,
  • 30. A.HISTAMIN&DECONGESTAN  DX: SEJARAH PSEUDOEPHEDRIN, (PHENYLPROPANOLAMINE)/PPA,DIPHENH YDRAMINE, CHLORPHENIRAMINE  GJL:- DEPRESI, GG RESP, - HIPEREXCITABILITY - TREMOR, SEIZURES, HIPERACTIVITY - VOMIT, MIDRIASIS, HIPERTERMIA - DISORIENTASI - BRADICARD/TACHICARD
  • 31.  PROG: BAIK  TREAT: 1. < 1 J INTAKEEMESIS 2. ACTIVATED CHARCOAL 3. SUPPORTIVE: INFUSE, O2 4. OBAT SEDATIVE HIPERACVTIVE (DIAZEPAM,PHENOBARBITAL) 5. PROPANOLOLTACHYCARDI 6. ATROPINE BRADYCARD